BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Cashflow Statement
0.000.00%
- TRY10.00bn
- TRY14.98bn
- TRY2.69bn
- 18
- 31
- 60
- 24
Annual cashflow statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 49.9 | 1.24 | 577 | 1,372 | 98.6 |
| Depreciation | |||||
| Non-Cash Items | 47.6 | 3.91 | 180 | -1,015 | 550 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -67 | -364 | -254 | 589 | -109 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 53 | -326 | 800 | 1,585 | 1,259 |
| Capital Expenditures | -287 | -441 | -1,447 | -1,511 | -692 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -43.7 | 1.1 | -0.671 | 101 | 12.8 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -331 | -440 | -1,448 | -1,410 | -679 |
| Financing Cash Flow Items | -10.9 | -23.7 | -86.1 | -316 | 0.312 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 361 | 835 | 229 | -28.7 | -693 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 83.5 | 69.1 | -419 | 147 | -114 |